Ch. Salmon

930 total citations
59 papers, 589 citations indexed

About

Ch. Salmon is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Ch. Salmon has authored 59 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 23 papers in Physiology and 14 papers in Genetics. Recurrent topics in Ch. Salmon's work include Blood groups and transfusion (37 papers), Erythrocyte Function and Pathophysiology (22 papers) and Diabetes and associated disorders (9 papers). Ch. Salmon is often cited by papers focused on Blood groups and transfusion (37 papers), Erythrocyte Function and Pathophysiology (22 papers) and Diabetes and associated disorders (9 papers). Ch. Salmon collaborates with scholars based in France, United Kingdom and Nigeria. Ch. Salmon's co-authors include P. Rouger, Jean‐Pierre Cartron, M. Lopez, J.C. Petit, Norbert Claude Gorin, Y Parlier, A Gerbal, A Najman, G Duhamel and R David and has published in prestigious journals such as The Lancet, FEBS Letters and Trends in biotechnology.

In The Last Decade

Ch. Salmon

50 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ch. Salmon France 14 355 167 132 112 94 59 589
C. Wasastjerna Finland 13 157 0.4× 62 0.4× 128 1.0× 74 0.7× 50 0.5× 48 500
T Kubo Japan 11 206 0.6× 61 0.4× 90 0.7× 140 1.3× 59 0.6× 17 473
Hans‐Peter Lohrmann Germany 10 263 0.7× 49 0.3× 99 0.8× 323 2.9× 39 0.4× 18 705
H Tonthat France 9 211 0.6× 86 0.5× 190 1.4× 364 3.3× 85 0.9× 13 766
Sven‐Aage Killmann Denmark 17 432 1.2× 61 0.4× 284 2.2× 68 0.6× 62 0.7× 39 848
Moore Ma United States 12 351 1.0× 59 0.4× 220 1.7× 182 1.6× 121 1.3× 30 664
Fabio Timeus Italy 15 212 0.6× 57 0.3× 266 2.0× 133 1.2× 60 0.6× 48 663
Wayne Borcherding United States 13 108 0.3× 54 0.3× 313 2.4× 237 2.1× 69 0.7× 21 733
Joseph P. Abraham United States 11 250 0.7× 28 0.2× 129 1.0× 74 0.7× 28 0.3× 19 601
Dzung T. Le United States 11 339 1.0× 63 0.4× 278 2.1× 230 2.1× 56 0.6× 15 778

Countries citing papers authored by Ch. Salmon

Since Specialization
Citations

This map shows the geographic impact of Ch. Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Salmon more than expected).

Fields of papers citing papers by Ch. Salmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch. Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Salmon. The network helps show where Ch. Salmon may publish in the future.

Co-authorship network of co-authors of Ch. Salmon

This figure shows the co-authorship network connecting the top 25 collaborators of Ch. Salmon. A scholar is included among the top collaborators of Ch. Salmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch. Salmon. Ch. Salmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salmon, D., P. Lambin, A.M. Couroucé, et al.. (1990). Essai de prédiction de l'évolution vers le SIDA d'une cohorte de 77 séropositifs : intérêt de l'antigénémie p24 et du taux des IgA sériques. 33(1). 21–29.
2.
Rouger, P., et al.. (1987). Therapeutic human monoclonal antibodies: from the laboratory to clinical trials. Trends in biotechnology. 5(8). 217–219. 3 indexed citations
3.
Rouger, P., et al.. (1986). Expression of blood group antigens including HLA markers in human adult liver. Tissue Antigens. 27(2). 78–86. 32 indexed citations
4.
Villartay, Jean‐Pierre de, P. Rouger, Jean‐Yves Muller, & Ch. Salmon. (1985). HLA antigens on peripheral red blood cells: analysis by flow cytofluorometry using monoclonal antibodies. Tissue Antigens. 26(1). 12–19. 20 indexed citations
5.
Salmon, Ch., et al.. (1984). Adverse Transfusion Reactions Associated with aPrecipitating Anti-C4 Antibody of Anti-Rodgers Specificity1. Vox Sanguinis. 47(3). 242–249. 4 indexed citations
6.
Gorin, Norbert Claude, A Najman, Luc Douay, et al.. (1984). Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas. European Journal of Cancer and Clinical Oncology. 20(2). 217–225. 18 indexed citations
7.
Lambin, P., et al.. (1984). Adverse Transfusion Reactions Associated with a Precipitating Anti‐C4 Antibody of Anti‐Rodgers Specificity1. Vox Sanguinis. 47(3). 242–249. 44 indexed citations
8.
Gorin, Norbert Claude, A Najman, Ch. Salmon, et al.. (1979). High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases. European Journal of Cancer (1965). 15(9). 1113–1119. 22 indexed citations
9.
Lopez, M., et al.. (1979). Activity of IgG and IgM ABO Antibodies against Some Weak A (A3, Ax, Aend) and Weak B (B3, Bx) Red Cells. Vox Sanguinis. 37(5). 281–285. 4 indexed citations
10.
Chastang, Claude, et al.. (1978). Validation de paternité au sein d'un trio père-mère-enfant à partir des marqueurs génétiques. Description d'un programme d'aide à la décision. Détermination de la séquence optimale d'examens.. 20(1). 1 indexed citations
11.
Cartron, Jean‐Pierre, et al.. (1977). Antigen site distribution among weak A' red cell populations. A study of A3, Ax and Aend variants.. PubMed. 32(2). 233–44. 9 indexed citations
12.
Yvart, J, et al.. (1974). Etude comparée de diverses méthodes de mise en évidence de l'antigène Du. PubMed. 17(3). 201–209. 3 indexed citations
13.
Habibi, B. & Ch. Salmon. (1972). SEPTIC SHOCK FROM BACTERIAL CONTAMINATION OF TRANSFUSED BLOOD. The Lancet. 300(7781). 830–831. 1 indexed citations
14.
Salmon, Ch.. (1971). Structure et fonctionnement du locus ABO. PubMed. 14(1). 9–23. 1 indexed citations
15.
Salmon, Ch., et al.. (1970). Mémoire OriginauxLes phénotypes Aend: Étude immunologique et génétique*. 13(3).
16.
Mannoni, P, et al.. (1970). Dépistage et identification automatique d'allo-anticorps anti-érythrocytaires. PubMed. 13(4). 343–355. 6 indexed citations
17.
Gerbal, A, et al.. (1970). Les phénotypes Aend. PubMed. 13(3). 243–250. 3 indexed citations
18.
Salmon, Ch., et al.. (1969). Le complexe génique DIV (C)-. PubMed. 12(2). 239–247. 14 indexed citations
19.
Salmon, Ch.. (1969). Groupes sanguins ABO et fonctionnement génétique. PubMed. 12(1). 97–117. 1 indexed citations
20.
Salmon, Ch., et al.. (1968). Étude de la variation des agglutinines anti-B selon le groupe sanguin. PubMed. 11(4). 305–313. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026